View Older Stories View More Recent Stories

Jan 29, 2020 04:05PM Lyra Therapeutics Completes $30 Million Series C Financing
Jan 27, 2020 02:00AM Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Jan 17, 2020 06:17AM Iterum Therapeutics (ITRM) Announces $52 Million Private Placement
Jan 17, 2020 06:15AM Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
Jan 17, 2020 06:15AM Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
Jan 10, 2020 11:00AM Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Jan 9, 2020 08:00AM Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference
Jan 7, 2020 08:05AM Cerebral Therapeutics Completes $35 Million Series B Financing
Jan 7, 2020 08:00AM Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
Dec 19, 2019 07:00AM FORMA Therapeutics Announces Closing of $100 Million Series D Financing
Dec 9, 2019 08:00AM Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development
Dec 5, 2019 08:17AM Black Diamond Therapeutics Closes $85 Million Series C Financing
Nov 21, 2019 07:00AM Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
Nov 18, 2019 05:16PM Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Nov 14, 2019 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 13, 2019 05:06PM Form SC 13D 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 11, 2019 11:05AM Chemical & Engineering News Names Frontier Medicines One of its 10 Chemistry Start-Ups to Watch
Nov 8, 2019 05:26PM Form SC 13G Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 4, 2019 08:30AM X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel
Oct 22, 2019 08:38AM PlacementTracker Publishes Q3 2019 PIPE and Private Placement Markets League Tables
Oct 18, 2019 05:04PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 11, 2019 04:12PM Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 10, 2019 09:05AM Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
Oct 1, 2019 08:00AM Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research
Sep 23, 2019 09:00AM Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019
Sep 23, 2019 09:00AM FierceBiotech names Frontier Medicines one of its "Fierce 15" biotech companies of 2019
Sep 18, 2019 08:00AM Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer
Sep 17, 2019 04:54PM Form SC 13D Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 10, 2019 08:00AM Nkarta Therapeutics Appoints Vice President of Regulatory Affairs
Sep 4, 2019 08:00AM Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials
Sep 3, 2019 07:00AM Achilles Therapeutics raises £100 million in oversubscribed Series B financing
Sep 3, 2019 02:00AM Achilles Therapeutics raises £100 million in oversubscribed Series B financing
Aug 27, 2019 09:21AM ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million
Aug 23, 2019 10:47AM ESSA Pharma Inc. (EPIX) Anounces Proposed $36M Share Offering and Concurrent Private Placement
Aug 23, 2019 10:37AM ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
Aug 14, 2019 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 14, 2019 07:30AM Solid Biosciences (SLDB) Tops Q2 EPS by 3c
Aug 14, 2019 07:25AM Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 7, 2019 08:30AM Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer
Jul 31, 2019 09:05AM Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies
Jul 31, 2019 08:30AM Vor Biopharma Appoints Dr. Bill Lundberg to Its Board of Directors
Jul 30, 2019 05:20PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 26, 2019 07:27AM Solid Biosciences (SLDB) Announces $60 Million Private Placement of Common Stock and Warrants
Jul 26, 2019 07:25AM Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors
Jul 24, 2019 09:00AM Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection
Jul 15, 2019 09:00AM RA Capital Management Closes First Venture Fund
Jul 10, 2019 04:32PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 25, 2019 09:00AM Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease
Jun 4, 2019 07:00AM Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
May 15, 2019 04:51PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
View More Recent Stories View Older Stories